413 related articles for article (PubMed ID: 25244495)
1. Diagnostic Values For Club Cell Secretory Protein (CC16) in Serum of Patients of Combined Pulmonary Fibrosis and Emphysema.
Kokuho N; Ishii T; Kamio K; Hayashi H; Kurahara M; Hattori K; Motegi T; Azuma A; Gemma A; Kida K
COPD; 2015 Aug; 12(4):347-54. PubMed ID: 25244495
[TBL] [Abstract][Full Text] [Related]
2. Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE).
Papaioannou AI; Kostikas K; Manali ED; Papadaki G; Roussou A; Spathis A; Mazioti A; Tomos I; Papanikolaou I; Loukides S; Chainis K; Karakitsos P; Griese M; Papiris S
PLoS One; 2016; 11(6):e0157789. PubMed ID: 27337142
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
[TBL] [Abstract][Full Text] [Related]
4. Differing Expression of Cytokines and Tumor Markers in Combined Pulmonary Fibrosis and Emphysema Compared to Emphysema and Pulmonary Fibrosis.
Xu L; Bian W; Gu XH; Shen C
COPD; 2017 Apr; 14(2):245-250. PubMed ID: 28128990
[TBL] [Abstract][Full Text] [Related]
5. Comparison of clinical characteristics and outcomes between combined pulmonary fibrosis and emphysema associated with usual interstitial pneumonia pattern and non-usual interstitial pneumonia.
Sugino K; Nakamura Y; Ito T; Isshiki T; Sakamoto S; Homma S
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jul; 32(2):129-37. PubMed ID: 26278692
[TBL] [Abstract][Full Text] [Related]
6. [Correlation of lymphocytes and PIIINP with the combined pulmonary fibrosis and emphysema].
Wei XH; Wu XY; Wang JH; Thakur A; Ma AQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jul; 26(7):675-8. PubMed ID: 20619092
[TBL] [Abstract][Full Text] [Related]
7. Use of serum clara cell 16-kDa (CC16) levels as a potential indicator of active pulmonary fibrosis in systemic sclerosis.
Hasegawa M; Fujimoto M; Hamaguchi Y; Matsushita T; Inoue K; Sato S; Takehara K
J Rheumatol; 2011 May; 38(5):877-84. PubMed ID: 21239758
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato/polymyositis.
Kumánovics G; Minier T; Radics J; Pálinkás L; Berki T; Czirják L
Clin Exp Rheumatol; 2008; 26(3):414-20. PubMed ID: 18578962
[TBL] [Abstract][Full Text] [Related]
9. Surgical Outcomes of Lung Cancer Patients with Combined Pulmonary Fibrosis and Emphysema and Those with Idiopathic Pulmonary Fibrosis without Emphysema.
Sato S; Koike T; Hashimoto T; Ishikawa H; Okada A; Watanabe T; Tsuchida M
Ann Thorac Cardiovasc Surg; 2016 Aug; 22(4):216-23. PubMed ID: 27052999
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
Xue M; Guo Z; Cai C; Sun B; Wang H
Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
[TBL] [Abstract][Full Text] [Related]
11. [Chronic obstructive pulmonary disorder (COPD) patients with the syndrome of combined pulmonary fibrosis and emphysema, compared to patients with emphysema alone].
Weiner P; Novitzky T; Weiner D; Beckerman M
Harefuah; 2013 May; 152(5):294-8, 308, 307. PubMed ID: 23885455
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic pulmonary fibrosis with emphysema: evidence of synergy among emphysema and idiopathic pulmonary fibrosis in smokers.
Mitchell PD; Das JP; Murphy DJ; Keane MP; Donnelly SC; Dodd JD; Butler MW
Respir Care; 2015 Feb; 60(2):259-68. PubMed ID: 25389350
[TBL] [Abstract][Full Text] [Related]
13. An autopsy study of combined pulmonary fibrosis and emphysema: correlations among clinical, radiological, and pathological features.
Inomata M; Ikushima S; Awano N; Kondoh K; Satake K; Masuo M; Kusunoki Y; Moriya A; Kamiya H; Ando T; Yanagawa N; Kumasaka T; Ogura T; Sakai F; Azuma A; Gemma A; Takemura T
BMC Pulm Med; 2014 Jun; 14():104. PubMed ID: 24972672
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of pulmonary inflammation in combined pulmonary fibrosis and emphysema.
Zhao Y; Cui A; Wang F; Wang XJ; Chen X; Jin ML; Huang KW
Chin Med J (Engl); 2012 Sep; 125(17):3015-21. PubMed ID: 22932172
[TBL] [Abstract][Full Text] [Related]
15. Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case-control study.
Xue C; Wu N; Li X; Qiu M; Du X; Ye Q
BMC Pulm Med; 2017 Nov; 17(1):144. PubMed ID: 29149883
[TBL] [Abstract][Full Text] [Related]
16. [A comparison of clinical features between patients with idiopathic pulmonary fibrosis combined with emphysema and without emphysema].
Ma JW; Li ZH; Xu H; Wang HJ; Kang J; Yu RJ
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):173-6. PubMed ID: 23856138
[TBL] [Abstract][Full Text] [Related]
17. Clinical features, anti-cancer treatments and outcomes of lung cancer patients with combined pulmonary fibrosis and emphysema.
Minegishi Y; Kokuho N; Miura Y; Matsumoto M; Miyanaga A; Noro R; Saito Y; Seike M; Kubota K; Azuma A; Kida K; Gemma A
Lung Cancer; 2014 Aug; 85(2):258-63. PubMed ID: 24894326
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers for lung epithelium injury in occupational hexavalent chromium-exposed workers.
Li P; Li Y; Zhang J; Yu SF; Tong W; Hu X; Jia G
J Occup Environ Med; 2015 Apr; 57(4):e45-50. PubMed ID: 25851191
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis.
Ryerson CJ; Hartman T; Elicker BM; Ley B; Lee JS; Abbritti M; Jones KD; King TE; Ryu J; Collard HR
Chest; 2013 Jul; 144(1):234-240. PubMed ID: 23370641
[TBL] [Abstract][Full Text] [Related]
20. Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation.
Moon SW; Park MS; Kim YS; Jang J; Lee JH; Lee CT; Chung JH; Shim HS; Lee KW; Kim SS; Lee SH; Yoon HI
BMC Pulm Med; 2019 Oct; 19(1):177. PubMed ID: 31615505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
